Evidence map›Paper›PMID 19690868›Full record

ReviewWorld journal of urology2009

Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.

Linda D Cardozo, Philip E V A Van Kerrebroeck, David R Staskin

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01482676 (Investigating the Role of microRNAs in the Regulation of Gene Expression and Organ Remodeling During Lower Urinary Tract Dysfunction, Including Bladder Pain Syndrome/Interstitial Cystitis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01482676 completednot on this mapstarted 2010, after this paper: background citation

Investigating the Role of microRNAs in the Regulation of Gene Expression and Organ Remodeling During Lower Urinary Tract Dysfunction, Including Bladder Pain Syndrome/Interstitial Cystitis (BPS), and Overactive Bladder Syndrome (OAB)

TypeobservationalSponsorInsel Gruppe AG, University Hospital BernRan2010 to 2012Enrolled103ConditionsProstatic Hyperplasia, Urinary Bladder Neck Obstruction, Cystitis, Interstitial
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Linda D CardozoDepartment of Urogynaecology, King’s College Hospital, London SE5 9RS, UK. lcardozo@compuserve.com
Philip E V A Van Kerrebroeck
David R Staskin
Boston University · USKing's College Hospital · GBMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTraditionally, urinary frequency and/or urgency incontinence have been the primary outcome measurements for the symptom complex of overactive bladder (OAB). However, urgency, by definition, precedes urgency incontinence, and drives frequency and nocturia in OAB and should be considered in this pivotal role. MATERIALS AND

methodsReview of published literature on this topic.

resultsThe management of urgency is evolving as of major clinical importance to patients. Recent use of diary-based urgency metrics has advanced our knowledge of the presence and nature of urgency symptoms, the impact on QoL and the response to treatment options.

conclusionIt is logical that the management of the number of urgency episodes and the degree of urgency, as well as the impact and bother associated with this core symptom are all taken into consideration along with patient interpretation to facilitate an effective outcome.

Indexed as

HumansMuscarinic AntagonistsUrinary Bladder, OveractiveUrinary Incontinence, UrgeMuscarinic Antagonists

Identifiers

PMID19690868
OpenAlexW1976724310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.